8-K filings disclosing entry into or termination of material definitive agreements (Items 1.01, 1.02), daily from SEC EDGAR.
On July 21, 2026, ACRES Commercial Realty Corp.'s subsidiary entered Amendment No. 5 to a Master Repurchase Agreement with JPMorgan Chase Bank, extending the maturity date from July 21, 2026 to July 21, 2028.
On July 21, 2026, Allurion exchanged 392,766 common shares for pre-funded warrants with RTW affiliates and terminated a November 2025 securities purchase agreement. Debt remains outstanding.
ARMOUR Residential REIT amended its equity sales agreement to increase authorized common stock for issuance by 25,000,000 shares. Articles of Amendment increased authorized common stock from 175,000,000 to 250,000,000 shares effective July
CPS securitized approximately $734.51 million of subprime automotive receivables and issued $716.88 million of asset-backed Notes in five classes on July 22, 2026.
Digital Brands Group entered into a securities purchase agreement on July 23, 2026, to issue a $3.5M convertible promissory note and an equity line of credit for up to $100M in common stock.
Elme Communities entered into purchase and sale agreement to sell Riverside Apartments (1,222 units, Alexandria VA) for $250 million, with closing targeted September 14, 2026. Amended Bethesda sale agreement for closing by August 11, 2026.
Healthy Extracts issued $258,750 principal convertible promissory note to LABRYS FUND II, L.P. on July 17, 2026. Net proceeds $225,000. Convertible after 180 days at $2.00/share or 75% of lowest closing bid price (15 trading days prior). Mo
Board approved plan of sale and dissolution; company to liquidate assets, repay liabilities, and distribute proceeds to stockholders pending stockholder approval at 2026 annual meeting.
Trust amended Sponsor Agreement, entered Authorized Participant Agreement with Marex Capital Markets, and Master Purchase and Sale Agreement with JSCT LLC to enable staking of crypto assets. Trust Agreement amended to create Sponsor Share c
Hercules Capital issued $325 million in aggregate principal amount of 6.300% Notes due 2031. Net proceeds to be used for debt repayment, investments, and general corporate purposes.
INVO Fertility entered into an Any Market Purchase Agreement with Alumni Capital LP on July 24, 2026, granting the right to sell up to $15 million (expandable to $50 million) of common stock. Proceeds designated for clinic acquisitions and
Company issued $2,000,000 Class B Incremental Note convertible into common stock and 305,810 Class B Incremental Common Warrants to accredited investor on July 21, 2026, pursuant to existing purchase agreement.
Lee Enterprises amended its Stock Purchase Agreement with investors to modify standstill provisions, permitting investors owning >10% of common stock to purchase shares under Rule 10b5-1 trading plans.
Lifted Liquids Inc., subsidiary of LFTD Partners, entered into agreement to sell principal operations facility at 5511 95th Avenue, Kenosha, Wisconsin for $1,500,000. Closing scheduled September 16, 2026.
Lisata Therapeutics terminated merger agreement with Kuva Labs dated March 6, 2026 after Kuva failed to obtain financing for $4.00/share tender offer. Kuva must pay $2M termination fee. Board will explore strategic alternatives.
Limbach Holdings and subsidiaries executed Third Amendment to credit facility with Wheaton Bank & Trust, increasing revolving credit from $100M to $125M and reducing applicable margins effective July 24, 2026.
Matador Resources entered into Securities Purchase Agreement to acquire Paloma Permian for $1.275 billion cash (including $63.75M escrow). Closing expected Q4 2026 with June 1, 2026 effective date.
BTIG terminated the At-The-Market Sales Agreement effective immediately on July 23, 2026. No termination penalties apply.
Company redomesticated from Colorado to Texas corporation effective July 20, 2026. Adopted new charter and bylaws; entered into indemnification agreements with directors and officers.
Safety Insurance Group entered into Agreement and Plan of Merger with MAPFRE U.S.A. Corp. whereby Merger Subsidiary will merge with the Company; stockholders will receive $105.00 per share in cash.